To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded $18,832,956 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 118 grants at over 100 hospitals in 15 countries.
SIOPe DIPG/DMG Registry
Renewal of the European DIPG/DMG Registry
Massachusetts General Hospital – $50,000
Targeted Protein Degradation for DIPG Therapy
CONNECT2007 - $385,794
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients with Recurrent and/or Progressive High-Grade Central Nervous System (CNS) Tumors and Meningiomas which Express Somatostatin Type 2A Receptors and Demonstrate Uptake on DOTATATE
CONNECT2109A - $705,764
CONNECT2109A: A molecularly-guided phase II study of ribociclib and everolimus in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG)
CONNECT Consortium - $278,619
Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors
Institute of Cancer Research – $113,747
Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG
Institute of Cancer Research – $498,716
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical
Sydney Children’s Hospital – $195,327
Phase I/II Study of Oral DFMO and AMXT1501 for DIPG/DMG